Ranks of donor-recipient histocompatibility for human transplantation.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 4904280)

Published in Science on February 27, 1970

Authors

F T Rapaport, J Dausset

Articles by these authors

Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci U S A (1990) 3.09

Antibody-induced redistribution of HL-A antigens at the cell surface. Eur J Immunol (1972) 2.58

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 2.14

Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03

[The Center for the Study of Human Polymorphism]. Presse Med (1986) 1.94

Genetics of HLA disease association. Annu Rev Genet (1981) 1.74

Immunologic responses in cancer patients. Surg Gynecol Obstet (1965) 1.72

The major histocompatibility complex in man. Science (1981) 1.72

A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1985) 1.69

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A (1998) 1.63

Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58

Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A (2001) 1.53

Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A (1984) 1.52

The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol (2001) 1.50

An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 1.46

Analysis of 221 renal transplants: influence of cross-reactions between donor and recipient HL-A antigens. Transplant Proc (1971) 1.45

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A (1997) 1.44

SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci U S A (1999) 1.44

Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med (1998) 1.44

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol (1999) 1.41

Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40

Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A (2001) 1.38

HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum Immunol (1982) 1.37

The bacterial induction of homograft sensitivity. I. Effects of sensitization with group A streptococci. J Exp Med (1965) 1.37

The bacterial induction of homograft sensitivity. II. Effects of sensitization with staphylococci and other microoorganisms. J Exp Med (1965) 1.36

Heterophile antibodies in human transplantation. J Clin Invest (1968) 1.35

A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. Tissue Antigens (1978) 1.35

The association of the HL-A antigens with diseases. Clin Immunol Immunopathol (1974) 1.34

Delayed hypersensitivity status of burned patients. Surg Forum (1966) 1.33

Polymorphic restriction endonuclease fragment segregates and correlates with the gene for HLA-B8. Proc Natl Acad Sci U S A (1983) 1.33

Clusters of HLA class II beta restriction fragments describe allelic series. Proc Natl Acad Sci U S A (1984) 1.32

A study of HL-A antigens in human organs. Transplantation (1970) 1.32

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32

The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30

Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28

The HL-A system sub-loci and their importance in transplantation. Transplant Proc (1969) 1.27

A rational approach to a common goal: the equitable distribution of organs for transplantation. JAMA (1987) 1.26

Use of the Auto-Analyzer to perform serological tests for syphilis. Study of 1,009 sera using a complement fixation test with the cardiolipidic antigen. Int Arch Allergy Appl Immunol (1967) 1.23

An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A (1994) 1.23

Serologic factors in human transplantation. Ann Surg (1967) 1.22

HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. Tissue Antigens (1982) 1.19

Theoretical analysis of a physical mapping strategy using random single-copy landmarks. Proc Natl Acad Sci U S A (1991) 1.19

Improved control of partial DNA restriction enzyme digest in agarose using limiting concentrations of Mg++. Nucleic Acids Res (1989) 1.18

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 1.18

Immunoferritin study of the distribution of HL-A antigens on human blood cells. J Immunol (1971) 1.17

Human transplantation antigens: the HL-A (Hu-1) system and its homology with the mouse H-2 system. Transplantation (1968) 1.17

HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol (1999) 1.16

Critical evaluation of histocompatibility in 179 renal transplants. Lancet (1971) 1.16

The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication? Immunogenetics (1989) 1.14

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol (2001) 1.12

HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis (1982) 1.11

Probable heploid expression of HL-A antigens on human spermatozoon. Nature (1970) 1.10

First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet (1986) 1.10

Implication of HLA-G molecule in heart-graft acceptance. Lancet (2000) 1.09

Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.09

Cellular factors. Immunologic tolerance: irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness. Transplant Proc (1977) 1.07

Drug-induced hemolysis. Annu Rev Med (1967) 1.06

DNA polymorphism of HLA class I and class II regions. Immunol Rev (1985) 1.06

Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. J Immunol (1979) 1.06

Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat Genet (1993) 1.06

Decline of natural killer cell activity in sublethally irradiated mice. J Natl Cancer Inst (1978) 1.05

A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem (2000) 1.05

Joint report of the Second International Workshop on Canine Immunogenetics. Transplant Proc (1976) 1.05

Some contributions of the HL-A complex to the genetics of human diseases. Transplant Rev (1975) 1.05

Letter: HL-A antigen W27--a genetic link between ankylosing spondylitis and Reiter's syndrome? N Engl J Med (1974) 1.04

HLA and susceptibility to Hodgkin's disease. Immunol Rev (1983) 1.04

p21WAF-1 reorganizes the nucleus in tumor suppression. Proc Natl Acad Sci U S A (1998) 1.04

Immunologic studies in thermal injury: heterophile antibodies. Proc Soc Exp Biol Med (1967) 1.04

Subsets of malignant lymphomas in children related to the cell phenotype. Blood (1979) 1.03

Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. Proc Natl Acad Sci U S A (2000) 1.03

Immunological effects of thermal injury. I. Inhibition of spermatogenesis in guinea pigs. J Exp Med (1969) 1.03

HLA-G gene polymorphism segregation within CEPH reference families. Hum Immunol (1997) 1.02

Appearance of cytoskeletal components on the surface of leukemia cells and of lymphocytes transformed by mitogens and Epstein-Barr virus. Proc Natl Acad Sci U S A (1980) 1.02

Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02

Relationship of human blood group antigens and antibodies to survival of skin homografts. Transplantation (1966) 1.01

Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood (1981) 1.01

Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet (1998) 1.01

A linkage disequilibrium map of the MHC region based on the analysis of 14 loci haplotypes in 50 French families. Eur J Hum Genet (2000) 1.01

HLA-G revisited. Immunol Today (1996) 1.00

Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci (2001) 1.00

Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 1.00

Immunologic sequelae of thermal injury. Ann N Y Acad Sci (1968) 1.00

HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics (1986) 0.99

HLA-G: a tolerance molecule from the major histocompatibility complex. Immunol Today (1999) 0.99

Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res (1999) 0.98

Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens. J Clin Invest (1968) 0.98

[A new antigen of the system HL-A (Hu-1): the antigen 15, possible allele of the antigens 1, 11, 12]. Nouv Rev Fr Hematol (1968) 0.98

Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc (1971) 0.97

Kinetics of humoral responsiveness in severe thermal injury. Ann Surg (1976) 0.97

Separation of HL-A transplantation antigen specificities. Transplantation (1970) 0.96

The case for a living emotionally related international kidney donor exchange registry. Transplant Proc (1986) 0.96

Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum Immunol (1995) 0.96

[The sub-loci of the HL-A system. The main system of histocompatibility in man]. Presse Med (1969) 0.96

[The second sub-locus of the HL-A system]. Nouv Rev Fr Hematol (1969) 0.96

Associations between restriction fragment length polymorphisms detected with a probe for human 21-hydroxylase (21-OH) and two clinical forms of 21-OH deficiency. Hum Genet (1986) 0.95